Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Holders of 5% or more of MESO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mesoblast Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| George Gregory | 13G/A | 22.36%288.5M shares | +0.77 ppfrom 21.59% | Sep 12, 20252 filings | Mar 11, 2026 | SEC |
| Gueck William J. | 13G | 5.00%64.5M shares | New | Sep 16, 20251 filing | Sep 16, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Mesoblast Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 20264:07 PM ET | George Gregoryand 3 others | 13G/A | 22.36%288.5M shares | +0.77 ppfrom 21.59% | Mar 6, 2026 | SEC |
| Sep 16, 20257:22 PM ET | Gueck William J. | 13G | 5.00%64.5M shares | New | Sep 12, 2025 | SEC |
| Sep 12, 202511:55 AM ET | George Gregoryand 3 others | 13G/A | 21.59%275.9M shares | – | Sep 11, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Mesoblast Ltd shares.
No Form 144 notices for Mesoblast Ltd are on file.